Solid Biosciences (SLDB) Stock Highlights

4.96 | -2.94%

2024-11-21 05:17:43

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of speciality and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Its lead product candidate, the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients muscles. The companys pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Statistics

Range Today

4.9 5.1

Volume Today 376.8K

Range 1 Year

2.32 15.05

Volume 1 Year 93.55M

Range 3 Year

1.81 30.9

Volume 3 Year 129.7M

Range 10 Year

1.81 822.6

Volume 10 Year 193.39M

Highlights

Market Capitalization 234.53M (small)

Floating Shares 16.42M

Current Price 4.96

Price To Earnings -1.88

Price To Book 1.37

Earnings Per Share -3.09

Payout Ratio 0%

Performance

Latest -2.94%

1 Month -23.69%

3 Months -46.55%

6 Months -44.83%

1 Year +100%

3 Years -83.38%

5 Years -91.16%

10 Years -98.7%

Benchmarks

Market Capitalization

29 / 54

Gross Profits

0 / 39

Total Revenue

50 / 50

Total Rank

48 / 54

Free Cashflow

48 / 54

Performance 5 years

43 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.